510(k) Report

510(k) · Cleared

Cleared

Vascular Occlusion System (Trufill Pushable Coils and Trupush Coil Pusher)

K071962510(k) SpecialCleared Sep 26, 200772-day reviewClass II21 CFR 882.5950

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cordis Neurovascular, Inc. · HCG Device, Neurovascular Embolization

Cleared on Sep 26, 2007 as substantially equivalent to K983483 (Cordis Neurovascular, Inc., 1999) after a 72-day review. Its family tree reaches back 4 generations to 1989. 1 of the 41 devices in its family, counting itself, has a Class I recall. 32 later devices descend from it.

Decided
Sep 26, 2007
Review
72 days
Class
Class II
Product code
HCG
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K891688 (1989). 8 ancestors in all. 32 later devices descend from it, 1 citing it directly. 1 of the 41 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 1990: 2 other ancestors1994: 1 other ancestor1991: 1 other ancestor2008: 3 descendants cleared2014: 4 descendants cleared2015: 4 descendants cleared2013: 2 descendants cleared2017: 3 descendants cleared2009: 1 descendant cleared2021: 3 descendants cleared2022: 3 descendants cleared, 1 with a Class I recall12018: 3 descendants cleared2020: 1 descendant cleared2026: 3 descendants cleared2023: 1 descendant cleared2019: 1 descendant clearedK891688 · Coil and Coil Delivery System · Target Therapeutics · 1989K964367 · Ces Vascular Occlusion System · Cordis Neurovascular, Inc. · 1997K972881 · Ces Vascular Occlusion System · Cordis Neurovascular, Inc. · 1998K983483 · Vascular Occlusion System · Cordis Neurovascular, Inc. · 19991990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 2 other ancestors3 generations back: 2 other ancestors 1 generation forward: 1 descendant2 generations forward: 3 descendants3 generations forward: 6 descendants4 generations forward: 12 descendants, 1 with a Class I recall15 generations forward: 7 descendants6 generations forward: 3 descendants K983483 · Vascular Occlusion System · Cordis Neurovascular, Inc. · 1999K972881 · Ces Vascular Occlusion System · Cordis Neurovascular, Inc. · 1998K964367 · Ces Vascular Occlusion System · Cordis Neurovascular, Inc. · 1997K891688 · Coil and Coil Delivery System · Target Therapeutics · 19890+5
  1. Root · 4 generations backK891688 Coil and Coil Delivery SystemTarget Therapeutics · 1989
  2. 3 generations backK964367 Ces Vascular Occlusion SystemCordis Neurovascular, Inc. · 1997
  3. 2 generations backK972881 Ces Vascular Occlusion SystemCordis Neurovascular, Inc. · 1998
  4. 1 generation backK983483 Vascular Occlusion SystemCordis Neurovascular, Inc. · 1999
  5. This deviceK071962 Vascular Occlusion System (Trufill Pushable Coils and Trupush Coil…Cordis Neurovascular, Inc. · 2007
  6. Descendant · cites it directly · 31 of its ownK073442 Micrus Microcoil SystemsMicrus Endovascular Corporation · 2008
  7. Descendant · 2 generations on · 22 of its ownK081465 Axium Detachable Coil SystemMicro Therapeutics, Inc. · 2008 · Recalled
  8. Descendant · 3 generations on · 10 of its ownK123803 Reverse Medical Micro Vascular Plug (MVP) SystemReverse Medical Corporation · 2013
  9. Descendant · 2 generations on · 7 of its ownK082739 Micrus Microcoil Delivery SystemMicrus Endovascular Corporation · 2008
  10. Descendant · 3 generations on · 6 of its ownK133310 Axium Detachable Coil SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2014

Showing 5 of 32 descendants. See all descendants

Descendants cleared per year

2008: 32009: 12013: 22014: 42015: 42017: 32018: 32019: 12020: 12021: 32022: 32023: 12026: 3
2008high 4 (2014) · low 0 (2010)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 32 · See all
  • K073442Micrus Microcoil SystemsMicrus Endovascular Corporation · 2008 · cites it directly31descendants
  • K081465Axium Detachable Coil SystemMicro Therapeutics, Inc. · 2008 · 2 generations on22descendants
  • K123803Reverse Medical Micro Vascular Plug (MVP) SystemReverse Medical Corporation · 2013 · 3 generations on10descendants
  • K082739Micrus Microcoil Delivery SystemMicrus Endovascular Corporation · 2008 · 2 generations on7descendants
  • K133310Axium Detachable Coil SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 2014 · 3 generations on6descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K891688Coil and Coil Delivery SystemTarget Therapeutics1989—
−3K964367Ces Vascular Occlusion SystemCordis Neurovascular, Inc.1997—
−2K972881Ces Vascular Occlusion SystemCordis Neurovascular, Inc.1998—
−1K983483Vascular Occlusion SystemCordis Neurovascular, Inc.1999—
0 (this device)K071962Vascular Occlusion System (Trufill Pushable Coils and Trupush Coil Pusher)Cordis Neurovascular, Inc.2007—
+1K073442Micrus Microcoil SystemsMicrus Endovascular Corporation2008—
+2K081465Axium Detachable Coil SystemMicro Therapeutics, Inc.20082
+3K123803Reverse Medical Micro Vascular Plug (MVP) SystemReverse Medical Corporation2013—
+2K082739Micrus Microcoil Delivery SystemMicrus Endovascular Corporation2008—
+3K133310Axium Detachable Coil SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199020
199110
199410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200830
200910
201320
201440
201540
201730
201830
201910
202010
202130
202231
202310
202630
FIG. 1 — Lineage of K071962, 1989–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HCG device

  1. #1 K252700 Optima Coil System (Optima Packing Coil System)score 20.6 · 26 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K983483Vascular Occlusion System
Summary page 2
…dicates) TRUPUSIH Cordis - Intended Use Coil Pusher Neurovascular, K983483 HCG - Design Inc. -…
Cordis Neurovascular, Inc.1999—

Also cleared against K983483: 3 other devices →

What descends from it? (32)

See all 32

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K073442Micrus Microcoil SystemsMicrus Endovascular Corporation200831

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K220040CEREPAK Uniform, Uniform XL, Uniform 3D, Heliform Soft, Heliform XtraSoft, Heliform XL, Heliform XtraSoft…Medos International SARL · 2022 · 4 generations on · ◆ in the 2022 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 18 years and passes through 2 companies; a new generation was cleared every 7.4 years on median.
  • 1 of the 8 ancestors has a recall of any class.
  • Of its descendants, K073442 (Micrus Endovascular Corporation, 2008) has gone furthest, with 31 descendants of its own.
  • 3 other devices also cite its predicate K983483.

How does its category compare?

All HCG devices

HCG Device, Neurovascular Embolization: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · HCG

3in 2025

2007: 82008: 92009: 72010: 82011: 92012: 72013: 72014: 52015: 52016: 72017: 52018: 42019: 12020: 22021: 52022: 32023: 22024: 42025: 32026 (partial year): 4
2007high 9 (2008) · low 1 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HCG

107in 2025

2007: 50 days median2008: 71 days median2009: 48 days median2010: 72 days median2011: 78 days median2012: 30 days median2013: 67 days median2014: 66 days median2015: 60 days median2016: 37 days median2017: 97 days median2018: 173 days median2021: 103 days median2022: 114 days median2024: 49 days median2025: 107 days median2026 (partial year): 30 days median
2007high 173 (2018) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HCG

1in 2025

2007: 12008: 32010: 22011: 12013: 22014: 42022: 22024: 12025: 1, 1 Class I2026 (partial year): 1
2007high 4 (2014) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · HCG

537in 2025

2007: 3262008: 7302009: 8212010: 8512011: 8942012: 1,1462013: 1,1032014: 1,7292015: 1,5982016: 1,9912017: 2,4942018: 2,0582019: 1,7632020: 1,7542021: 2,2682022: 6632023: 5682024: 5522025: 537
2007high 2,494 (2017) · low 326 (2007)2025

MAUDE reports naming product code HCG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078501326
20089713730
20097480821
20108722851
20119781894
201273001,146
201376721,103
201456641,729
201556001,598
201673701,991
201759702,494
2018417302,058
20191—01,763
20202—01,754
2021510302,268
202231142663
20232—0568
20244491552
202531071 (1)537
20264301—

What is it indicated for?

The intended use of the TRUFILL® Vascular Occlusion System (TRUFILL® Pushable Coils and TRUPUSH® Coil Pusher) is as follows:

Pushable Coils may be used to reduce or block the rate of blood flow in vessels of the peripheral and neurovasculature. They are intended for use in the interventional radiologic management of arteriovenous malformations, arteriovenous fistulas, and other vascular lesions of the brain, spinal cord, and spine.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K071962: Vascular Occlusion System (Trufill Pushable Coils and Trupush Coil Pusher).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K071962

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026